Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 185 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
Fosdenopterin for molybdenum cofactor deficiency type A	Fosdenopterin	Molybdenum cofactor deficiency Type A	Endocrine Nutritional and Metabolic Disorders	2023	View \| Download
Favezelimab-Pembrolizumab for treating relapsed or refractory classical Hodgkin Lymphoma after 2 or more therapies	Favezelimab-pembrolizumab	Hodgkin lymphoma	Haematological Cancer and Lymphomas	2023	View \| Download
Favezelimab-pembrolizumab for treating metastatic PD-L1 positive colorectal cancer	Favezelimab-pembrolizumab	Colorectal cancer	Gastrointestinal Cancer , Oncology	2023	View \| Download
Evolocumab for preventing major cardiovascular events in adults with a high risk of cardiovascular events	Evolocumab	Cardiovascular events	Cardiovascular System	2023	View \| Download
Evobrutinib for treating relapsing multiple sclerosis	Evobrutinib	Multiple sclerosis (MS)	Neurology	2023	View \| Download
Eplontersen for hereditary transthyretin-mediated amyloid polyneuropathy	Eplontersen (ION-682884;AKCEA TTR-LRx)	Transthyretin-mediated amyloid polyneuropathy	Genetic Disorders	2023	View \| Download
Epcoritamab for treating relapsed or refractory follicular lymphoma	Epcoritamab (GEN-3013)	Follicular lymphoma	Haematological Cancer and Lymphomas	2023	View \| Download
Enfortumab vedotin with pembrolizumab for treating bladder cancer	Enfortumab vedotin (ASG-22ME; Padcev) , Pembrolizumab (Keytruda; MK-3475)	Bladder cancer	Urological Cancer	2023	View \| Download
Encorafenib with binimetinib for treating metastatic BRAF V600 mutant non-small-cell lung cancer	Binimetinib (MEK162; MEK-162; ARRY-162) , Encorafenib (LGX818)	Non-small-cell lung cancer (NSCLC)	Lung and Respiratory Cancer	2023	View \| Download
Elinzanetant for the treatment of moderate to severe vasomotor symptoms (hot flashes) associated with the menopause	Elinzanetant	Post-menopausal vasomotor symptoms	Women's Health	2023	View \| Download